This document discusses glomerular diseases and their patterns based on four morphological components: glomeruli, tubules, interstitium, and blood vessels. It provides details on specific glomerular diseases including their presentations, causes, mechanisms of injury, histopathological features, and clinical courses. Key diseases discussed include acute proliferative glomerulonephritis, rapidly progressive glomerulonephritis, membranous nephropathy, minimal-change disease, and focal segmental glomerulosclerosis.
2. Disease patterns based on
FOUR morphologic components
1. Glomeruli
2. Tubules
3. Interstitium
4. Blood vessels
CSBRP-June-2014
3. Disease patterns based on
FOUR morphologic components
1. Glomeruli
Presents with hematuria / proteinuria
Puffiness of face / generalized edema
Oliguria / Azotemia
Usually immune mediated
CSBRP-June-2014
4. Disease patterns based on
FOUR morphologic components
1. Glomeruli
2. Tubules
Presents with inability to concentrate urine
Polyuria / nocturia / electrolyte disturbances
Acute renal failure
Azotemia
Usually due to toxins / infections / inheritedCSBRP-June-2014
5. Disease patterns based on
FOUR morphologic components
1. Glomeruli
2. Tubules
3. Interstitium
Presents with inability to concentrate urine
Acute renal failure
Pyuria
Usually due to Drugs / infections
CSBRP-June-2014
6. Disease patterns based on
FOUR morphologic components
1. Glomeruli
2. Tubules
3. Interstitium
4. Blood vessels
Presents with hypertension
Acute renal failure
Ischemic injury – papillary necrosis / infarcts
Usually due to congenital / DrugsCSBRP-June-2014
7. Disease patterns based on
FOUR morphologic components
These four components are interdependent
and disease affecting one may affect the
other components secondarily in the course
of time
Example:
1.Disease affecting the blood vessels affect invariably
other components
2.Severe glomerular damage impairs blood flow to the
tubules
CSBRP-June-2014
16. Mechanisms of glomerular
injury
• Ab mediated injury:
– Ab reacting with in situ Ag
• Intrinsic (fixed, insoluble – Type-IV collagen,
Mesangeal Ags)
• Extrinsic (molecule planted with in glomerulus)
– Exogenous – infective agents, drugs
– Endogenous – DNA, nuclear proteins Ig, Ag+Ab, IgA
– Circulating Ag+Ab complexes
• Cytotoxic antibodies
CSBRP-June-2014
17. Circulating Ag+Ab complexes
Ab have no immunological specificity for the
glomerular constituents, and the complexes
are localized within the glomeruli because of
their physicochemical properties and the
hemodynamic factors peculiar to the
glomerulus
Ag+Ab complexes are trapped in the glomeruli
CSBRP-June-2014
19. Circulating Ag+Ab complexes
Ag+Ab complexes are trapped in the glomeruli
Activation of complement
Recruitment of inflammatory cells
Damage
CSBRP-June-2014
20. Localization of immune complexes in the glomerulus
1-Subepithelial humps
2-Epimembranous deposits
3-Subendothelial deposits
4-Mesangial deposits
CSBRP-June-2014
21. Localization of immune complexes in the glomerulus
Factors affecting the glomerular localization:
– Molecular charge
– Size of these reactants
Subepithelial localization:
Highly cationic immunogenic molecules tend to cross the GBM and reside
in subepithelial region
Subendothelial localization:
Highly anionic macromolecules
Mesangial deposition:
Neutrally charged molecules
Immune complexes containing these molecules gets deposited in the
mesangium
NOTE: Very large molecules are not nephritogenic and are
cleared by the macrophage system
CSBRP-June-2014
22. Antibodies to glomerular cell Ags
• Abs to mesangial cell antigens
– Mesnagiolysis
– Mesangial cell proliferation
• Ab to endothelial cell Ags
– Endothelial injury and
– Thrombosis
• Abs to visceral epithelial cell Ags
– Protineuria
CSBRP-June-2014
23. Cell mediated immunity in
glomerulonephritis
Evidence:
•Presence of macrophages
•Presence of sensitized T-lymphocytes and
their products in the glomerulus
CSBRP-June-2014
24. Epithelial cell injury
Caused by Ab to Visceral epithelil cell Ags
– Drugs
– Toxins
– Experimentally by Puromycin
Changes in epithelial cells:
– Vacuolations
– Effacement of foot processes
– Retraction &
– Detachment of cells from GBM
CSBRP-June-2014
30. Acute proliferative glomerulonephritis
(Post Streptococcal GN)
• Proliferation of glomerular cells
• Neutrophilic infiltration
• Typically immune complex mediated
• Inciting Ag may be:
– Exogenous (eg - infective agents)
– Endogenous (eg - SLE)
CSBRP-June-2014
31. Acute proliferative glomerulonephritis
(Post Streptococcal GN)
• Children 6-10yrs of age / rarely adults
• Common infective agent is Streptococcus
– Nephritogenic strains of Streptococcus
• M protein in cell wall
• Griffith types 12, 4, 1
– Other Antigens:
• Nephritis associated Streptococcal plasmin receptor (NAP1r)
• Eotoxin B (SepB)
• Zymogen precursor (zSepB)
– Mechanism: Planted Ag / Ag+Ab / Altered GBM
CSBRP-June-2014
32. Acute Proliferative Glomerulonephritis
(Post Streptococcal GN)
Morphology: Diffuse & Global
•Enlarged hypercellular glomeruli
– Infiltration by Leucocytes & macrophages
– Proliferation of Endothelial & mesangial cells
•Obliteration of lumen of capillaries
•Interstitial edema
•Tubular red cell casts
•Immunofluorescence:
– Sparse and focal IgG, Ig M in GBM and C3 in mesangium
•Electron microscopy:
– Subepithelial electron dense HUMPS
– Subepithelial and mesangial deposits
CSBRP-June-2014
37. Rapidly Progressive GN
[Crescentic GN]
Salient features:
•Indicative of severe glomerular injury
•Progresses rapidly, if not treated death
occurs in weeks to 3 months
•Most common histological feature is the
presence of crescents in glomeruli
•Glomerular injury is immunologically
mediated
CSBRP-June-2014
39. Rapidly Progressive GN
[Crescentic GN]
1-Anti-GBM Ab induced disease:
•Linear deposits of IgG and C3 in GBM
•Goodpasture syndrome: Anti-GBM Ab may cross react
with pulmonary alveolar BM resulting in pulmonary
hemorrhages
– Ag is non-collagenous portion of the α3 chain of Type-IV
collagen
– Exposure to various solvents (in paints & dyes) has been
implicated
– HLA-DRB1
•Plasmapheresis helps
CSBRP-June-2014
40. Rapidly Progressive GN
[Crescentic GN]
2-Immune complex induced:
•Granular pattern of deposits
•In addition to crescents there is cellular
proliferation in the glomerular tufts
•Plasmapheresis not helpful
•Underlying disease must be treated
– HS purpura
– SLE
CSBRP-June-2014
41. Rapidly Progressive GN
[Crescentic GN]
3-Pauci-Immune type:
•No anti-GBM Abs / Immune complexes
•Have circulating anti-neutrophil cytoplasmic Ab
(ANCA)
•Recent concept: Probably these cases are
examples of polyangiitis which is limited to
glomeruli
CSBRP-June-2014
42. Rapidly Progressive GN
[Crescentic GN]
Morphology:
•Enlarged kidneys, pale, petechial hemorrhages on the
cortical surface
•Crescent formation:
– Proliferation of parietal cells + monocytes/Macrophages + Fibrin
+ PMNs
– Crescents obliterate Bowman space
•Immunofluorescence:
– Granular immune deposits
– Goodpasture syndrome shows linear GBM Ig+C deposits
•In pauci-immune type there is vasculitis
CSBRP-June-2014
43. Rapidly Progressive GN
[Flea bitten kidney]
Causes for Flea bitten kidneyCauses for Flea bitten kidney:
RPGN
Benign nephrosclerosis
Bacterial endocarditis
CSBRP-June-2014
47. Membranous nephropathy
CSBRP-June-2014
• Common cause of NS in adults
• A form of chronic immune complex–mediated
disease
Characterized by:
– Diffuse thickening of glomerular capillary wall due to
Ig deposits in the subepithelial side of GBM
Causes:
– Drugs: Penicillamine, Captopril, gold, NASID
– Cancers: Lung, Colon, Melanoma
– SLE
– Infections: Malaria, HBV, HCV, Syphilis
– Other autoimmune diseases
48. Membranous nephropathy
CSBRP-June-2014
Morphology:
– Diffuse thickening of glomerular capillary wall due to
Ig deposits in the subepithelial side of GBM
– Antigens can be demonstrated in the deposits
– Paucity of PMNs and Monocytes and platelets
– C3 deposition
– Effacement of foot processes
– There may be progressive sclerosis of glomeruli
50. Membranous nephropathy
Clinical features:
• Insidious onset
• Mostly as nephrotic syndrome
• 15% present with non-nephrotic proteinuria
• 15% - 35% Hematuria and hypertension
• First rule out the secondary causes as it
can reverse the injury
51. Membranous nephropathy
Clinical Course:
• Indolent disease
• Nonselective proteinuria and does not respond
well to corticosteroid therapy
• Progression is associated with increasing
sclerosis of glomeruli, rising serum creatinine and
development of hypertension
• About 10% die or progress to renal failure within
10 years, and no more than 40% eventually
develop renal insufficiency
52. Minimal-change disease
CSBRP-June-2014
• Most frequent cause of NS in children
• Peak incidence 2-6yrs of age
• Diffuse effacement of foot processes
• Characteristic feature: Dramatic response
to steroids
• In a few cases there is preceeding
respiratory infection
53. Minimal-change disease
CSBRP-June-2014
Pointers to immunological basis:
•Associated with respiratory infections /
immunization
•Dramatic response to steroids
•Associated with other atopic disorders
•Associated some HLA haplotypes
•More common in Hodgkin’s lymphoma
54. Minimal-change disease
CSBRP-June-2014
Basis of the disease:
Visceral epithelial cell injury
•Loss of glomerular polyanion > defective
charge barrier > proteinuria
•Mutations in podocyte proteins
–Nephrin, podocin
•Mutation in nephrin gene causes a
hereditary form of congential nephrotic
syndrome – Finnish type
55. Minimal-change disease
CSBRP-June-2014
Morphology:
– Glomeruli are normal by light microscopy
– EM:
• Loss of foot processes
• Cytoplasm shows vacuolations, swelling of villi
– No Ig, C deposition in glomeruli
– PCT show lipid and protein deposition
•Prognosis: is very good. 90% of children
respond to steroids
57. Minimal-change disease
Clinical Features:
• Despite massive proteinuria, renal function
remains good
• No hypertension / No hematuria
• Respond rapidly to corticosteroid therapy
• Some patients may become steroid-dependent
or resistant
• Long-term prognosis is excellent
• Adults are slower to respond - long-term
prognosis is also excellent
59. Focal segmental glomerulosclerosis
(FSGS)
This lesion is characterized by:
Sclerosis of some, but not all, glomeruli
(thus, it is focal)
and
In the affected glomeruli, only a portion of
the capillary tuft is involved
(thus, it is segmental)
61. FSGS-Classification and Types
FSGS occurs in the following settings:
• Idiopathic focal segmental glomerulosclerosis
• In association with other known conditions:
– HIV infection (HIV-associated nephropathy)
– Heroin addiction (heroin nephropathy)
– Sickle-cell disease, and
– Massive obesity
• As a secondary event:
– Scarring of previously active necrotizing lesions (e.g., IgA
nephropathy)
– Renal ablation
– in advanced stages of other renal disorders, such as:
• Reflux nephropathy
• Hypertensive nephropathy
• Unilateral renal agenesis
• Mutations in genes that encode proteins localized to the slit
diaphragm
– e.g., Podocin, α-Actinin 4, and TRPC6 (transient receptor potential
calcium channel-6)
62. FSGS - Pathogenesis
• Epithelial damage that is the hallmark of FSGS
• Damage mediated by different mechanisms:
– Circulating cytokines and
– Genetic defects affecting components of the slit
diaphragm
• The hyalinosis and sclerosis are due to:
– Entrapped plasma proteins &
– Increased ECM deposition
63. ESGS - Morphology
• Initial lesions involve the juxtamedullary
glomeruli
• In the sclerotic segments there is collapse of
capillary loops
• Increase in matrix, and segmental deposition of
plasma proteins along the capillary wall
(hyalinosis)
• Lipid droplets and foam cells are often present
• Glomeruli that do not show segmental lesions
usually appear normal on light microscopy but
may show increased mesangial matrix
64. ESGS - Morphology
• Diffuse effacement of foot processes -
both sclerotic and nonsclerotic areas
EM:
• Focal detachment of the epithelial cells
• Denudation of the underlying GBM
IF:
• IgM and C3 (in the sclerotic areas and/or
in the mesangium)
65. ESGS - Morphology
• A morphologic variant of FSGS, called
collapsing glomerulopathy
– characterized by retraction and/or collapse of
the entire glomerular tuft
– proliferation and hypertrophy of glomerular
visceral epithelial cells
– there is associated prominent tubular injury
with formation of microcysts
• It has poor prognosis
68. FSGS – Clinical Course
• Response to steroids – variable
• Children have better prognosis
• Progression to renal failure – variable
– 20% rapid
• Recurrence in allograft 25%-50%
CSBRP-June-2014
69. Membranoproliferative
glomerulonephritis (MPGN)
• MPGN = mesangiocapillary GN
• MPGN accounts for 10-20% NS in
children and young adults
• MPGN can be Primary or Secondary
Histology – Basic alterations:
• Alterations in BM
• proliferation of glomerular cells
• Leucocyte infiltration
CSBRP-June-2014
70. Membranoproliferative
glomerulonephritis (MPGN)
• MPGN can be Primary or Secondary
Primary MPGN (Based on EM, IF and LM)
• Type-I
– Mesangiocapillary glomerulonephritis
– Immune complexes to planted Ags (HBV,HCV)
– Activation of both Complement pathways
• Type-II
– Dense deposit disease
– Activation of alternate complement pathway (low C3,
Normal C1, C4)
CSBRP-June-2014
72. Membranoproliferative
glomerulonephritis (MPGN)
Morphology: (Types I&II)
•Glomeruli are large, hypercellular, lobular
accentuation
•Hypercellularity is due to:
– Neutrophilic infiltration
– Mesangial cell proliferation
•GBM is thickened degmentaly
•GBM in silver stain – “Tram track”
CSBRP-June-2014
73. Membranoproliferative
glomerulonephritis (MPGN)
Type-I & II differ in EM appearances:
•Type-I:
– Subendothelail electron dense deposits
– Occasionally – mesangial, subepithelial deposits
– C3 - granular deposits
– C1, C4 and IgG deposits
•Type-II:
– Lamina densa converted into irregular ribbon like electron dense
structure
– C3 – granular deposits
– IgG, C1 and C4 are absent
– Hence, has a higher frequency of hypocomplementemia and C3
nephritic factor than type I MPGN
CSBRP-June-2014
81. IgA nephropathy
(Berger Disease)
CSBRP-June-2014
Pathogenesis:
•IgA levels are increased in these patients
•IgA1 is nephritogenic
•Activates alternate complement pathway
•Genetic influence:
– Runs in some families
– Certain HLA genotype
•Seen in Celiac disease
•Initiating events are not known
84. IgA nephropathy
(Berger Disease)
CSBRP-June-2014
Clinical features:
•Any age (more common in older children / young
adults)
•Present with hematuria (after respiratory infection)
•Hematuria lasts for several days and then
subsides only to recur every few months
•Renal functions are maintained for decades
•Recur in transplanted kidney
•Slowly progressive
90. Thin GBM lesion
(Benign Familial Hematuria)
• Hematuria is usually an incidental finding
• Diffuse thinning of GBM (150-200nm)
• Mild to moderate proteinuria
• Renal functions are preserved
• Prognosis is excellent
Genes:
• Mutations in alfa-3 or alfa-4 chains of type-IV
collagen
CSBRP-June-2014
91. Chronic Glomerulonephritis
• End stage of many glomerulonephritides
– MPGN, IgA nephropathy, MGN, RPGN, FSGS
• Post Streptococcal GN is rare to end in
CGN
CSBRP-June-2014
109. Lupus Nephritis
•40-75% SLE cases
•Class I – minimal lesion
•Class II - Mesangial lupus GN
•Class III -Focal segmental GN
•Class IV -Diffuse proliferative GN
•Class V - Membranous GN
•Calss VI – sclerosing lupus nephritis
110.
111.
112.
113.
114. Morphology
Diabetic Nephropathy:
Kidneys are the prime targets of DM
Renal failure is the second leading cause
of death in DM
3 lesions are encountered:
1-Glomerular lesions
2-Renal vascular lesion
3-Pyelonephritis (necrotizing papillitis)
116. Diffuse mesangial sclerosis (DMS):
--Diffuse increase in mesangial matrix
--Thickening of BM
When DMS becomes marked the pateint
suffers from Nephrotic syndrome
Morphology - Diabetic Nephropathy
117.
118. Nodular glomerulosclerosis:
Other name: Kimmelsteil-Wisoln’s lesion
-- This is very pathognomonic of DM
-- It’s the major cause of morbidity & mortality
-- Seen in 15-30% of long standing DM
Micro: Ball like deposits of a laminated matrix
situated in the periphery of the glomerulus
Nodules are PAS +
also contains trapped mesangial cells
This sclerosis induces sufficient ischemia to cause overall
fine scarring of the kidneys (finely granular cortical
surface)
Morphology - Diabetic Nephropathy
FIGURE 20-1 A, Low-power electron micrograph of renal glomerulus. CL, capillary lumen; EP, visceral epithelial cells with foot processes; END, endothelium; MES, mesangium. B, Schematic representation of a glomerular lobe. (A, Courtesy of Dr. Vicki Kelley, Brigham and Women's Hospital, Boston, MA.)
Arrows= 20nm Filtration slits with thin diaphragm
FIGURE 20-2 Glomerular filter consisting, from bottom to top, of fenestrated endothelium, basement membrane, and foot processes of epithelial cells. Note the filtration slits (arrows) and diaphragm situated between the foot processes. Note also that the basement membrane consists of a central lamina densa, sandwiched between two looser layers, the lamina rara interna and lamina rara externa. (Courtesy of Dr. Helmut Rennke, Brigham and Women's Hospital, Boston, MA.)
FIGURE 20-3 A simplified schematic diagram of some of the best-studied proteins of the glomerular slit diaphragm. CD2AP, CD2-associated protein
There is little confusion in the terminology. Best and easy to remember is Fixed and Planted Ags.
Fixed = already present in the glomerulus.
Planted = not normally present in the glomerulus but are planted there.
FIGURE 20-5 Localization of immune complexes in the glomerulus: (1) subepithelial humps, as in acute glomerulonephritis; (2) epimembranous deposits, as in membranous nephropathy and Heymann glomerulonephritis; (3) subendothelial deposits, as in lupus nephritis and membranoproliferative glomerulonephritis; (4) mesangial deposits, as in IgA nephropathy; (5) basement membrane. EN, endothelium; EP, epithelium; LD, lamina densa; LRE, lamina rara externa; LRI, lamina rara interna; MC, mesangial cell; MM, mesangial matrix. (Modified from Couser WG: Mediation of immune glomerular injury. J Am Soc Nephrol 1:13, 1990.)
FIGURE 20-6 Epithelial cell injury. The postulated sequence is a consequence of antibodies specific to epithelial cell antigens, toxins, cytokines, or other factors causing injury; this results in foot process effacement and sometimes detachment of epithelial cells and protein leakage through defective GBM and filtration slits.
FIGURE 20-7 Mediators of immune glomerular injury including cells and soluble mediators
Post Streptococcal GN (Old term)
Post Streptococcal GN (Old term)
Post Streptococcal GN (Old term)
Recollect the terms we used in the previous lectures:
Diffuse / Focal
Global / Segmental
FIGURE 20-9 Acute proliferative glomerulonephritis. A, Normal glomerulus. B, Glomerular hypercellularity is due to intracapillary leukocytes and proliferation of intrinsic glomerular cells. C, Typical electron-dense subepithelial “hump” and a neutrophil in the lumen. D, Immunofluorescent stain demonstrates discrete, coarsly granular deposits of complement protein C3, corresponding to “humps” illustrated in part C. (A–C, courtesy of Dr. H. Rennke, Brigham and Women's Hospital, Boston, MA. D, courtesy of D. J. Kowaleska, University of Washington, Seattle, WA.)
FIGURE 20-10 Crescentic glomerulonephritis (PAS stain). Note the collapsed glomerular tufts and the crescent-shaped mass of proliferating parietal epithelial cells and leukocytes internal to Bowman capsule. (Courtesy of Dr. M.A. Venkatachalam, University of Texas Health Sciences Center, San Antonio, TX.)
FIGURE 20-11 Crescentic glomerulonephritis. Electron micrograph showing characteristic wrinkling of GBM with focal disruptions (arrows).
FIGURE 20-11 Crescentic glomerulonephritis. Electron micrograph showing characteristic wrinkling of GBM with focal disruptions (arrows).
FIGURE 20-12 Membranous nephropathy. A, Silver methenamine stain. Note the marked diffuse thickening of the capillary walls without an increase in the number of cells. There are prominent “spikes” of silver-staining matrix (arrow) projecting from the basement membrane lamina densa toward the urinary space, which separate and surround deposited immune complexes that lack affinity for the silver stain. B, Electron micrograph showing electron-dense deposits (arrow) along the epithelial side of the basement membrane (B). Note the effacement of foot processes overlying deposits. CL, capillary lumen; End, endothelium; Ep, epithelium. C, Characteristic granular immunofluorescent deposits of IgG along GBM. D, Diagrammatic representation of membranous nephropathy. (A, Courtesy of Dr. Charles Lassman, UCLA School of Medicine, Los Angeles, CA.)
FIGURE 20-12 Membranous nephropathy. A, Silver methenamine stain. Note the marked diffuse thickening of the capillary walls without an increase in the number of cells. There are prominent “spikes” of silver-staining matrix (arrow) projecting from the basement membrane lamina densa toward the urinary space, which separate and surround deposited immune complexes that lack affinity for the silver stain. B, Electron micrograph showing electron-dense deposits (arrow) along the epithelial side of the basement membrane (B). Note the effacement of foot processes overlying deposits. CL, capillary lumen; End, endothelium; Ep, epithelium. C, Characteristic granular immunofluorescent deposits of IgG along GBM. D, Diagrammatic representation of membranous nephropathy. (A, Courtesy of Dr. Charles Lassman, UCLA School of Medicine, Los Angeles, CA.)
FIGURE 20-12 Membranous nephropathy. A, Silver methenamine stain. Note the marked diffuse thickening of the capillary walls without an increase in the number of cells. There are prominent “spikes” of silver-staining matrix (arrow) projecting from the basement membrane lamina densa toward the urinary space, which separate and surround deposited immune complexes that lack affinity for the silver stain. B, Electron micrograph showing electron-dense deposits (arrow) along the epithelial side of the basement membrane (B). Note the effacement of foot processes overlying deposits. CL, capillary lumen; End, endothelium; Ep, epithelium. C, Characteristic granular immunofluorescent deposits of IgG along GBM. D, Diagrammatic representation of membranous nephropathy. (A, Courtesy of Dr. Charles Lassman, UCLA School of Medicine, Los Angeles, CA.)
FIGURE 20-13 Minimal-change disease. A, Glomerulus stained with PAS. Note normal basement membranes and absence of proliferation. B, Ultrastructural characteristics of minimal-change disease include effacement of foot processes (arrows) and absence of deposits. CL, capillary lumen; M, mesangium; P, podocyte cell body.
Recollect the terms we used in the previous lectures:
Diffuse / Focal
Global / Segmental
The hyalinosis and sclerosis stem from entrapment of plasma proteins in extremely hyperpermeable foci and increased ECM deposition
The hyalinosis and sclerosis stem from entrapment of plasma proteins in extremely hyperpermeable foci and increased ECM deposition
The hyalinosis and sclerosis stem from entrapment of plasma proteins in extremely hyperpermeable foci and increased ECM deposition
The hyalinosis and sclerosis stem from entrapment of plasma proteins in extremely hyperpermeable foci and increased ECM deposition
FIGURE 20-14 Focal segmental glomerulosclerosis, PAS stain. A, Low-power view showing segmental sclerosis in one of three glomeruli (at 3 o'clock). B, High-power view showing hyaline insudation and lipid (small vacuoles) in sclerotic area
FIGURE 20-15 Collapsing glomerulopathy. Visible are retraction of the glomerular tuft, narrowing of capillary lumens, proliferation and swelling of visceral epithelial cells, and prominent accumulation of intracellular protein absorption droplets in the visceral epithelial cells. The appearance is identical in cases wherein the etiology is idiopathic to cases associated with HIV infection. Silver methenamine stain. (Courtesy of Dr. Jolanta Kowalewska, University of Washington, Seattle, WA.)
FIGURE 20-8 Focal segmental glomerulosclerosis associated with loss of renal mass. The adaptive changes in glomeruli (hypertrophy and glomerular capillary hypertension), as well as systemic hypertension, cause epithelial and endothelial injury and resultant proteinuria. The mesangial response, involving mesangial cell proliferation and ECM production together with intraglomerular coagulation, causes the glomerulosclerosis. This results in further loss of functioning nephrons and a vicious circle of progressive glomerulosclerosis.
In summary, a pathologic diagnosis of MPGN requires not merely light microscopic recognition of an appropriate pattern of glomerular injury, but, more importantly, specific ultrastructural changes that are the diagnostic features of these diseases. Many types of glomerular disease can produce light microscopic patterns of glomerular injury that mimic MPGN, but the diagnostic term MPGN should be reserved for the specific types of disease just described, and should be further qualified as MPGN type I, MPGN type II or MPGN type III. Otherwise, a diagnosis of MPGN would be of no value for predicting prognosis, identifying possible causes and directing therapy.
Type-I Planted antigens: HCV, HBV
When the deposits in the subepithelial zone are as numerous as in membranous glomerulopathy, the glomerulonephritis may be designated type III membranoproliferative glomerulonephritis or mixed membranous and proliferative glomerulonephritis (although the term type III MPGN also has been used for another patterns of glomerular injury characterized by irregular electron-lucent thickening of glomerular basement membranes).
FIGURE 20-16 The alternative complement pathway in MPGN. Note that C3NeF, an antibody present in the serum of individuals with membranoproliferative glomerulonephritis, acts at the same step as properdin, serving to stabilize the alternative pathway C3 convertase, thus enhancing C3 activation and consumption, causing hypocomplementemia.
Type-I Planted antigens: HCV, HBV
FIGURE 20-18 A, Membranoproliferative glomerulonephritis, type I. Note discrete electron-dense deposits (arrows) incorporated into the glomerular capillary wall between duplicated (split) basement membranes (double arrows), and in mesangial regions (M); CL, capillary lumen. B, Dense-deposit disease (type II membranoproliferative glomerulonephritis). There are markedly dense homogeneous deposits within the basement membrane proper. CL, capillary lumen. In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. C, Schematic representation of patterns in the two types of membranoproliferative GN. In type I there are subendothelial deposits; type II is characterized by intramembranous dense deposits (dense-deposit disease). In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. (A, Courtesy of Dr. Jolanta Kowalewska, University of Washington, Seattle, WA.)
FIGURE 20-18 A, Membranoproliferative glomerulonephritis, type I. Note discrete electron-dense deposits (arrows) incorporated into the glomerular capillary wall between duplicated (split) basement membranes (double arrows), and in mesangial regions (M); CL, capillary lumen. B, Dense-deposit disease (type II membranoproliferative glomerulonephritis). There are markedly dense homogeneous deposits within the basement membrane proper. CL, capillary lumen. In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. C, Schematic representation of patterns in the two types of membranoproliferative GN. In type I there are subendothelial deposits; type II is characterized by intramembranous dense deposits (dense-deposit disease). In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. (A, Courtesy of Dr. Jolanta Kowalewska, University of Washington, Seattle, WA.)
FIGURE 20-17 Membranoproliferative glomerulonephritis, showing mesangial cell proliferation, increased mesangial matrix (staining black with silver stain), basement membrane thickening with segmental splitting, accentuation of lobular architecture, swelling of cells lining peripheral capillaries, and influx of leukocytes (endocapillary proliferation).
FIGURE 20-18 A, Membranoproliferative glomerulonephritis, type I. Note discrete electron-dense deposits (arrows) incorporated into the glomerular capillary wall between duplicated (split) basement membranes (double arrows), and in mesangial regions (M); CL, capillary lumen. B, Dense-deposit disease (type II membranoproliferative glomerulonephritis). There are markedly dense homogeneous deposits within the basement membrane proper. CL, capillary lumen. In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. C, Schematic representation of patterns in the two types of membranoproliferative GN. In type I there are subendothelial deposits; type II is characterized by intramembranous dense deposits (dense-deposit disease). In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. (A, Courtesy of Dr. Jolanta Kowalewska, University of Washington, Seattle, WA.)
FIGURE 20-18 A, Membranoproliferative glomerulonephritis, type I. Note discrete electron-dense deposits (arrows) incorporated into the glomerular capillary wall between duplicated (split) basement membranes (double arrows), and in mesangial regions (M); CL, capillary lumen. B, Dense-deposit disease (type II membranoproliferative glomerulonephritis). There are markedly dense homogeneous deposits within the basement membrane proper. CL, capillary lumen. In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. C, Schematic representation of patterns in the two types of membranoproliferative GN. In type I there are subendothelial deposits; type II is characterized by intramembranous dense deposits (dense-deposit disease). In both, mesangial interposition gives the appearance of split basement membranes when viewed in the light microscope. (A, Courtesy of Dr. Jolanta Kowalewska, University of Washington, Seattle, WA.)
FIGURE 20-19 IgA nephropathy. A, Light microscopy showing mesangial proliferation and matrix increase. B, Characteristic deposition of IgA, principally in mesangial regions, detected by immunofluorescence.
FIGURE 20-19 IgA nephropathy. A, Light microscopy showing mesangial proliferation and matrix increase. B, Characteristic deposition of IgA, principally in mesangial regions, detected by immunofluorescence.
FIGURE 20-19 IgA nephropathy. A, Light microscopy showing mesangial proliferation and matrix increase. B, Characteristic deposition of IgA, principally in mesangial regions, detected by immunofluorescence.
FIGURE 20-19 IgA nephropathy. A, Light microscopy showing mesangial proliferation and matrix increase. B, Characteristic deposition of IgA, principally in mesangial regions, detected by immunofluorescence.
FIGURE 20-19 IgA nephropathy. A, Light microscopy showing mesangial proliferation and matrix increase. B, Characteristic deposition of IgA, principally in mesangial regions, detected by immunofluorescence.
Normal GBM thickening is 300-4000nm.
FIGURE 20-21 Primary glomerular diseases leading to chronic glomerulonephritis (GN). The thickness of the arrows reflects the approximate proportion of patients in each group who progress to chronic GN: poststreptococcal (1% to 2%); rapidly progressive (crescentic) (90%), membranous (30% to 50%), focal segmental glomerulosclerosis (50% to 80%), membranoproliferative GN (50%), IgA nephropathy (IgAN, 30% to 50%).
FIGURE 20-22 Chronic glomerulonephritis. A Masson trichrome preparation shows complete replacement of virtually all glomeruli by blue-staining collagen. (Courtesy of Dr. M.A. Venkatachalam, Department of Pathology, University of Texas Health Sciences Center, San Antonio, TX.)
Glomerular BM is diffusely thickenend throughout the entire length. (EM can detect this lesion very early before any changes can be appreciated in renal function).
Source: AFIP fascicle
Source: AFIP fascicle
Source: AFIP fascicle.
Source: AFIP fascicle.
Source: AFIP fascicle.
Source: AFIP fascicle.
Source: AFIP fascicle.
In the diagram in slide 2 are my conceptions of the major distinctions between the three major categories of FSGS. There is a perihilar predominance of sclerosis in one variant of FSGS, a glomerular tip location for a distinctive injury in the tip lesion variant of FSGS, and a particular type of collapsing pattern of destruction of capillaries and matrix expansion in the collapsing glomerulopathy variant of FSGS.
The diagram in Picture3 depicts perihilar segmental sclerosis, which is continuous with the afferent arteriole where the blood is coming into the glomerulus. A leading theory for the pathogenesis of this variant is single nephron hypertension, hyperperfusion, hyperfiltration. This is possibly analogous to a small local area of arteriosclerosis (arteriolosclerosis) where plasma constituents are exuding into the glomerular tuft much as plasma proteins exude into the walls of arterioles causing the hyaline arteriolosclerosis of hypertension. The PAS-stained section in Picture 4 shows the perihilar location of sclerosis with hyalinosis and lipids vacuolation and an adhesion to Bowman's capsule. These are very distinctive and characteristic features of focal segmental glomerulosclerosis, but they are not specific. These features should be present in the absence of any other cause of focal glomerular scarring in order to diagnose FSGS.